What are the medications used to treat acute decompensated heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

The primary medications used to treat acute decompensated heart failure include intravenous diuretics, vasodilators, and inotropes, with loop diuretics such as furosemide being first-line therapy to reduce fluid overload and relieve congestion. The initial recommended dose of furosemide should be 20–40 mg i.v. (or equivalent) for patients with new-onset AHF or those with chronic, decompensated HF not receiving oral diuretics, and at least equivalent to the oral dose for those on chronic diuretic therapy 1.

Key Medications

  • Diuretics:
    • Loop diuretics like furosemide are recommended to improve symptoms, with monitoring of symptoms, urine output, renal function, and electrolytes during use 1, 2, 1.
    • The dose and duration should be adjusted according to the patient's symptoms and clinical status 1, 2, 1.
  • Vasodilators:
    • Intravenous vasodilators like nitroglycerin or nitroprusside can be used for symptomatic relief in AHF with systolic blood pressure >90 mmHg and without symptomatic hypotension 1.
    • They should be considered as initial therapy in patients with hypertensive AHF to improve symptoms and reduce congestion 1.
  • Inotropic agents:
    • Short-term, intravenous infusion of inotropic agents like dobutamine, dopamine, levosimendan, or phosphodiesterase III inhibitors may be considered in patients with hypotension and/or signs of peripheral hypoperfusion to maintain end-organ function 1.
    • However, inotropic agents are not recommended unless the patient is symptomatically hypotensive or hypoperfused due to safety concerns 1, 2, 1.

Additional Considerations

  • Morphine may be used cautiously for anxiety and dyspnea, but its routine use is not recommended due to potential harm 3.
  • Oxygen therapy should be administered to maintain saturation above 90%.
  • Treatment should be individualized based on the patient's hemodynamic profile, with close monitoring of vital signs, urine output, and electrolytes to guide therapy adjustments and prevent complications.
  • Thrombo-embolism prophylaxis is recommended in patients not already anticoagulated and with no contraindication to anticoagulation to reduce the risk of deep venous thrombosis and pulmonary embolism 1.

From the FDA Drug Label

Milrinone Lactate Injection is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. The medications used to treat acute decompensated heart failure include:

  • Milrinone (IV) 4 These patients may also be receiving other medications such as:
  • Digoxin
  • Diuretics as part of their treatment regimen.

From the Research

Medications for Acute Decompensated Heart Failure

The following medications are used to treat acute decompensated heart failure:

  • Diuretics, including:
    • Loop diuretics such as furosemide 5, 6, 7, 8, 9
    • Thiazide diuretics such as metolazone 5, 9
    • Potassium-sparing diuretics such as spironolactone 5, 9
  • Vasodilators, including:
    • Nitroglycerin 6, 7, 8
    • Nitroprusside 6, 7, 8
    • Nesiritide 6, 7, 8
  • Inotropes, including:
    • Dobutamine 6, 7, 8
    • Milrinone 6, 7, 8
  • Aquaretics, including:
    • Tolvaptan 5, 9

Diuretic Strategies

Diuretic strategies for acute decompensated heart failure include:

  • Early, aggressive administration of a loop diuretic 9
  • Initial furosemide dose of 2-2.5 times the patient's home dose 9
  • Addition of an adjunctive diuretic such as thiazide or acetazolamide if congestion persists 9
  • Continuous infusion of furosemide if decongestion targets are not met 9

Treatment Goals

The treatment goals for acute decompensated heart failure are to:

  • Decrease congestion 7
  • Decrease afterload 7
  • Decrease neurohormonal activation 7
  • Improve hemodynamics and symptoms 7
  • Reduce in-hospital events, re-hospitalizations, and mortality 7

References

Research

Update on the Management of Acute Decompensated Heart Failure.

Current treatment options in cardiovascular medicine, 2011

Research

Drug treatment of patients with decompensated heart failure.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2001

Research

Diuretic Strategies in Acute Decompensated Heart Failure: A Narrative Review.

The Canadian journal of hospital pharmacy, 2024

Related Questions

What are the key teaching points for rounds on a patient with Heart Failure with preserved Ejection Fraction (Hfpef) regarding the use of diuretics?
How to manage acute decompensated heart failure with metabolic alkalosis (high bicarbonate level) and a normal anion gap?
In a 72-year-old man with acute decompensated congestive heart failure who is awake, alert, using accessory respiratory muscles, has tachycardia, normotension, tachypnea, hypoxemia despite 8 L/min face mask oxygen, bilateral lower extremity edema, pulmonary edema on chest radiograph, acidemia, and hypercapnia, what is the best next step in management after initiating diuresis?
What are the possible explanations for an elderly female patient with ischemic heart disease (IHD) and poor left ventricular (LV) function, controlled on furosemide (Lasix), experiencing weight gain despite having a urine output that exceeds fluid intake?
What are the typical clinical features of acute decompensated heart failure and a simple step‑by‑step treatment plan?
What is the best course of action for a patient with a ruptured J-tube (jejunostomy tube) and a gastric stimulator, experiencing 10/10 pain in the left lower quadrant, who is due for Dilaudid (hydromorphone) in a few hours, and has allergies to Vancomycin (Vanco), iodine, and contrast?
What is the treatment for Kocuria rhizophila infections?
What type of infections does Kocuria rhizophila cause and in which patient demographics?
What is a visceral crisis in breast cancer patients?
What are the potential side effects of zinc supplementation?
Why is cardiac Extracorporeal Membrane Oxygenation (ECMO) necessary in cases of severe bupropion (Wellbutrin) overdose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.